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INTRODUCTION 
 Carcinoma of tongue, one of the commonest site for malignancies of 
oral cavity has gained importance by virtue of the organ’s anatomical and 
functional importance.  Along with other cancers of oral cavity like cheek, 
floor of mouth, lip it has a deleterious effect on functions like swallowing, 
speech, taste and respiration. 
 The presence of premalignant conditions has provided the way for 
early detection of susceptible persons.  With changing life style and 
increased incidence of tobacco abuse the tongue cancer is on the rise.  It is of 
interest that an increase in tongue cancer has been reported among young 
adult men.  The median age for individuals with tongue cancer is 
approximately 40 years.  Knowledge of tongue’s anatomy along with neck 
nodes, about 200 in number, is of utmost importance for managing these 
lesions and to get a better loco-regional control, as most of the failures occur 
in this level. 
 As with other oral cavity cancers, carcinoma tongue patients, also 
have the likelihood of developing a second primary tumour elsewhere in the 
upper aerodigestive tract.  This has been attributed to the field cancerisation 
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effect and this should be kept in mind during pre-treatment investigations 
and post-treatment follow up.  Management of these patients should provide 
a good control of the disease and a better functional outcome in terms of 
speech and most importantly swallowing.  Post-treatment rehabilitation is an 
essential element in treating these cases. 
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AIM OF THE STUDY 
¾ To evaluate association of risk factors with tongue cancers 
¾ To find out the age specific incidence and male:female ratio 
¾ To find the stage at presentation 
¾ To find out the site of commonest presentation anterior or posterior tongue 
¾ To assess the pattern of cervical metastasis from tongue cancer in 
relation to T status and location of cancer 
¾ To find out the number of patients taken for primary radiotherapy and 
its response 
¾ To study the role of surgery in management of primary and neck nodes 
¾ Compare the outcome of surgery following chemotherapy and 
radiotherapy 
¾ To study the role of chemotherapy in management of tongue cancer 
¾ To compare my results with literature 
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MATERIALS AND METHODS 
All patients who reported at oncology department diagnosed as a 
carcinoma tongue at Government Royapettah Hospital were included in the 
study. 
The patients either came to department directly or were referred from 
other departments and other hospitals after proving the malignancy by 
Histopathological examination. 
The study period was 25 months from September 2005 to September 
2007. 
Diagnosis was confirmed by HPE of specimen obtained by wedge 
biopsy of ulcer / growth. 
Detailed history regarding duration of symptoms, habits like smoking, 
alcoholism, tobacco chewing were obtained.  Baseline investigation which 
included a complete hemogram, blood biochemistry, X-Ray chest and X-ray 
mandible as required were done. 
Special investigation like MRI and CT scan done in few selected 
cases. 
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A thorough physical examination was done to assess the size and 
extent of tumour presence or absence of Ankyloglossia, involvement of 
adjacent structures.  Nodal status was assessed clinically.  Finally staged 
according to TNM staging.  Early cases categorized to T1-T2 advanced 
cases to T3-T4. 
The protocol followed at oncology department GRH is to subject the 
patient with advanced disease to combined modality compiling 
Radiotherapy and surgery. 
Radiotherapy was given as external beam Radiotherapy using 
radioactive cobalt 60. 
Dosage used in a range of radiation schedule was 4000-6000 CGY. 
200 CGY / day for 5 days a week for 5-7 weeks. 
Criteria for Response 
 Complete regression of tumour and node was taken as complete 
response.  Presence of residual lesion was considered as partial response. 
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 Surgery was done in the form of Hemi glossectomy, Partial 
glossectomy, sub total / Total glossectomy and composite resection. 
Management of neck nodes 
 Supra omo hyoid neck dissection (SOHND) in selective cases, 
Modified radical neck dissection (MRND) type I and Radical neck 
dissection (RND). 
 Few cases towards end of my study protocol underwent palliative 
chemotherapy. 
FOLLOW UP 
 Complete regression of the lesion were followed up with observation. 
 Residual lesions were followed with Radiotherapy chemotherapy or 
surgery. 
 After complete surgical resection adjuvant radiotherapy was given for 
advanced cases. 
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Case Criteria 
US intergroup R9501 as follows 
Major criteria     Minor criteria 
1. Margins positive   1. High grade tumour 
2. Extra capsular nodalspread  2. Lymphovascular invasion 
       3. Perineural invasion 
       4. Multiple positive nodes without 
           extracapsular nodalspread 
 Presence of one major or two minor criteria in post operative patients 
should receive standard post operative Radiotherapy or same radiotherapy 
with cisplatin 100 mg/m3 every 3 weeks in 3 doses. 
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LIMITATIONS 
1. There was a very high drop out rate even at the initial stage of study.  
Some patients were not willing for salvage surgery after RT. 
2. Because of short period available, patients could be followed for a 
minimum period only.  Hence adequate data regarding tumour free 
interval, survival period, exact recurrence rate were not available. 
3. Since most of the patients present at late stage of disease, proper 
evaluation of primary RT and surgery in early stage of disease could 
not be studied. 
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REVIEW OF LITERATURE 
ANATOMY 
 The tongue, organ of taste, speech, mastication and deglutition, is a 
mass of skeletal muscle covered by mucous membrane and with amidline 
fibrous septum separating the two muscular halves.  It is divided into 
anterior and posterior part by a V-shaped sulcus called sulcus terminals.  The 
stratified squamous epithelium is keratinized on the oral part and non-
keratinised on the pharyngeal part. 
 The mucous membrane of the anterior two thirds of the dorsum is 
roughened by the presence of three types of papillae: 
Filliform papillae  - No taste buds 
Fungiform papillae - Few taste buds 
Vallate papillae  - In front of sulcus terminalis 
     Numerous taste buds and glands in the sulcus  
that surrounds each vallate papilla 
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 The posterior third of the tongue is behind the sulcus terminalis and at 
the apex of the sulcus is a small depression, the foramen caecum.  There are 
no papillae behind the sulcus.  The smooth mucous membrane has a nodular 
appearance from the presence of underlying masses of mucous and serous 
glands and aggregation of lymphoid follicles.  Foliate papillae are a series of 
parallel folds of mucous membrane on the side of posterior part, site of 
numerous taste buds. 
MUSCLES 
Muscles of tongue are divided into intrinsic and extrinsic groups 
 The muscles of the intrinsic group are the superior longitudinal, 
inferior longitudinal, transverse and vertical. 
 The extrinsic group comprises genioglossus, Hyoglossus, styloglossus 
and palatoglossus. 
DEVELOPMENT 
 Tongue muscles are derived from occipital myotomes. 
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Epithelium 
a) Anterior 2/3rd – tuberculum impar and two lingual swellings i.e. 
from first branchial arch. 
b) Posterior 1/3rd – Midline Hypobranchial eminence (third arch) and 
posterior most from the fourth arch. 
BLOOD SUPPLY 
Artery 
¾ Lingual artery, a branch of external carotid artery 
¾ Small contribution to root from tonsillar branch of facial artery and 
ascending pharyngeal artery 
¾ The fibrous septum dividing the two halves of tongue prevents any 
significant anastomosis of blood vessels across the midline 
Venous Drainage 
¾ Lingual vein 
¾ Deep lingual vein – from the tip visible on the undersurface 
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¾ DLV joined by sublingual vein to form vena comitans of the 
hypoglossal nerve 
¾ DLV joins the lingual vein or facial or anterior jugular vein 
¾ Lingual veins usually joins the IJV 
Nerve Supply 
Motor 
 Hypoglossal nerve (except palatoglossus) 
Sensation – Anterior 2/3rd 
 Taste – Chorda tympani of lingual nerve 
 Common sensation – Trigeminal Component of lingual nerve 
Posterior 1/3rd 
 Taste & Common sensation – Glossopharyngeal nerve 
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Lymph drainage 
 A significant feature of tongue’s lymph drainage is that lymph from 
one side, especially of the posterior part, may reach nodes on both sides of 
neck. 
 Tip  - Submental nodes or directly to deep cervical nodes 
 Lateral - Ipsilateral submandibular or directly to deep  
cervical nodes 
 Central - Deep cervical nodes of either side 
 Posterior part- Directly and frequently bilateral to deep cervical  
nodes 
 Deep nodes usually involved are the jugulodigastric and jugulo-
omohyoid nodes. 
LEVEL OF NECK NODES 
Level I - Submental group 
Level II - Around the upper third of IJV and spinal accessory nerve  
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from the skull base down to level of carotid bifurcation 
(Hyoid bone on CT) 
Level III - Around the middle third of IJV from Carotid bifurcation  
to upper part of cricoid cartilage (where omohyoid 
crosses the IJV) 
Level IV - Lower third of IJV from cricoid cartilage to clavicle 
Level V - Along the lower half of spinal accessory nerve and  
transverse cervical artery. (Posterior triangle group 
including the supraclavicular nodes) 
Level VI - Anterior compartment group from the Hyoid bone to  
suprasternal notch, laterally between the medial border of 
the two sternomastoid muscle. 
Lever VII - Mediastinal nodes 
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ETIOLOGY AND PREMALIGNANT CONDITIONS 
 Life-style habits and social factors have a major impact on 
development of tongue cancer.  Epidemiological studies have shown that use 
of alcohol, tobacco (smoked or smokeless) and betelnut and panproducts is 
associated with a high risk. 
TOBACCO 
 The relationship between tobacco exposure to oral mucosa and 
disease development has been demonstrated strongly.  A clear dose-response 
relationship has been identified, with a greater risk being directly 
proportional to intensity and duration of exposure.  Risk decreased only 
gradually after cessation of tobacco. 
 Tobacco exposure can be by means of smoking or by smokeless 
tobacco.  The risk of malignancy is six-times that of non-smokers. 
 The risk of cancer was found to increase four-times in use of 
smokeless tobacco.  Smokeless tobacco is available in many forms like it is 
chewed alone or with pan (betel leaf, catechu, areca nut and slaked lime) or 
as a commercially available pan masala. Smoking and chewing tobacco was 
found to have a synergistic effect. 
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ALCOHOL 
 Alcohol is another strong independent risk factor for cancer with a 
multiplicative effect from combined exposure with tobacco. Alcohol may act 
as a promoter, an irritant or solvent to increase the solubility of carcinogens 
from tobacco leading to development of cancer.  Experimental evidence 
suggests that alcohol suppresses the efficiency of DNA repair after exposure 
to nitrosamine compounds.  Indirectly vitamin deficiency and poor 
detoxifying capability due to alcohol – induced liver function may promote 
carcinogenesis. 
DIET AND NUTRITION 
 Dietary factors may also have a role in the development of cancer.  
Diets having fresh fruit and vegetables, particularly those rich in vitamin A, 
have a protective effect against cancer and precancer. 
OTHER RISK FACTORS 
 Poor dental hygiene and chronic irritation from ill-fitting denture or a 
sharp tooth have also been implicated.  Genetic susceptibility is another 
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proven risk factor.  A direct link between human papilloma virus and oral 
cancer remains to be established. 
 Smoke, spirit, spicy food, syphilis, sepsis sharp tooth and 
susceptibility the S’s to be remembered in the etiology of oral cancer. 
PREMALIGNANT CONDITIONS 
Leukoplakia 
 Any white patch or plaque that cannot be characterized clinically or 
pathologically as any other disease.  Tobacco smoking and chewing are 
undoubtedly important etiological factors.  Leukoplakia may persist, regress 
spontaneously, recur or progress to cancer.  The incidence of ultimate 
malignant change in oral leukoplakia increases with increasing age of the 
lesion.  Studies have shown that leukoplakia of floor of mouth and ventral 
surface of tongue has a particularly high incidence of malignant change.  
This was due to pooling of soluble carcinogens in the sump of the floor of 
the mouth.  Oral cancer develops in 3-6% of leukoplakias.  Nodular or 
speckled leukoplakia are the most likely to undergo malignant change. 
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ERYTHROPLAKIA 
 Any lesion of the oral mucosa that presents as bright red velvety 
plaques which cannot be characterized clinically or pathologically as any 
other recognizable condition.  The incidence of malignant change in 
erythroplakia is 17-fold higher than in leukoplakia. 
SYPHILITIC GLOSSITIS 
 Prior to the antibiotic era syphilis was an important predisposing 
factor in the development of oral leukoplakia and cancer.  The syphilitic 
infection produces an interstitial glossitis with an endarteritis which results 
in atrophy of the overlying epithelium.  This atrophic epithelium appears to 
be more vulnerable to other irritant which cause cancer.  It should be noted 
that squamous cell carcinoma may arise in syphilitic glossitis even in the 
absence of leukoplakia. 
SIDEROPENIC DYSPHAGIA (Plummer – Vinson Syndrome) 
 The sideropenic dysphagia leads to epithelial atrophy, which in itself 
is excessively vulnerable to carcinogenic irritants. 
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SUBMUCUS FIBROSIS 
 Most important precancerous condition in India.  It is characterized by 
Juxta-epithelial fibrosis with atrophy or hyperplasia of overlying epithelium 
which also shows areas of dysplasia. 
ORAL LICHEN PLANUS 
 The relation of lichen planus with malignancy exists with erosive or 
atrophic lichenplanus. 
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CLINICAL FEATURES AND INVESTIGATIONS 
 The goal of evaluating a patient with oral cancer is to assess the extent 
of disease and to define the tumour type histologically. 
 The majority of tongue cancer present with persistent ulcer or sore.  It 
can also present with growth which is exophytic with areas of ulceration.  
The ulcer is hard in consistency with heaped-up and everted edges.  The 
floor is granular, indurated and bleeds readily.  Infiltration into deeper 
tissues cause pain.  Pain can also radiate to ears due to irritation of the 
lingual nerve which is referred to auriculotemporal nerve. 
 Patient can also present with profuse salivation, this is partly due to 
irritation of nerves of taste and partly due to difficulty in swallowing. 
 Ankyloglossia, that means inability to protrude the tongue is due to 
infiltration of lingual musculature by cancer.  There may be fetor oris 
(offensive smell), difficulty in speech and swallowing more often in 
posterior third tongue cancer. 
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 Growths at the posterior third of tongue often escapes notice and in 
these cases alteration of the voice, dysphagia and neck swelling will be the 
primary symptoms. 
INVESTIGATIONS 
 The clinician should evaluate any medical and nutritional problems.  
Common problems in patients with cancer are hepatic disease, pulmonary 
disease and malnutrition.  Dental consultation should be obtained for any 
sharp tooth or other precipitating factors and if radiation is being planned. 
1. Biopsy of the lesion is mandatory before treatment.  This can be done 
under local anaesthesia.  The biopsy should be deep and encompass a 
portion of tumour as well as adjacent normal appearing mucosa 
(Wedge biopsy).  Areas of necrosis or gross infection should be 
avoided as they may confuse the diagnosis.  Toludine blue staining 
can be used to target biopsies but has a high false positivity as 
inflammatory and non-cancerous lesions also stain.  It is not routinely 
recommended. 
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2. Fine needle aspiration cytology is applicable mainly to lumps in the 
neck, especially suspicious lymph nodes in a patient with known 
primary carcinoma. 
3. Chest X-Ray 
4. Plain radiograph is of limited value in assessing mandible 
involvement become atleast 50 percent of the calcified component of 
bone must be lost before any radiographic change is apparent. 
5. In this situation orthopantomogram will be effective but is limited in 
the ability to evaluate the symphysis and lingual cortex. 
6. CT of the mandible can be used in selected cases where the above 
imaging is inadequate.  CT gives information regarding the extent of 
mandibular involvement, malignant infiltration and cervical nodal 
disease. 
7. MRI can be used to determine soft tissue and perineural involvement.  
MRI gives excellent definition of the extent of cancer involving the 
tongue and may be especially useful where lesions are not visible on 
CT. 
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Indication for CT are 
a. in lesions abutting the mandible 
b. where marginal mandibulectomy is being planned 
c. to evaluate the clinically negative (No) neck 
d. in patients with large nodes to look for carotid artery 
involvement 
8. Laboratory investigations – These are non-specific and done to 
evaluate the patient’s fitness for surgery and to exclude concurrent 
medical illness.  These usually include a full blood count and renal 
and liver function tests. 
9. Dental consultation – dental scaling, removal of caries tooth. 
10. Laryngoscopy, bronchoscopy and oesophagoscopy for finding out any 
other primary lesions associated field cancerisation. 
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STAGING 
 TNM staging is a clinical staging system that allows to design 
treatment modality compare results and assess prognosis. 
PRIMARY TUMOUR (T) 
Tx - Primary tumour cannot be assessed 
T0 - No evidence of primary tumour 
Tis - Carcinoma insitu 
T1 - Tumour not more than 2 cm in greatest dimension 
T2 - Tumour more than 2 cm and not more than 4 cm in greatest  
dimension 
T3 - Tumour more than 4 cm in greatest dimension 
T4 - Tumour invades adjacent structures 
  (cortical bone, deep muscles of tongue etc.) 
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NODAL INVOLVEMENT 
Nx - Nodal status cannot be assessed 
N0 - No regional lymph node 
N1 - Presence of single ipsilateral lymphnode not more than 3 cms in  
greatest dimension 
N2: 
N2a - Single ipsilateral node more than 3 cm but not more than 6 cms  
in greatest dimension 
N2b - Multiple ipsilateral lymphnode none more than 6 cm in greatest  
dimension 
N2c - Bilateral or contralateral lymphnode none more than 6 cms in  
greatest dimension 
N3 - Lymphnode of any side more than 6 cm in greatest dimension 
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DISTANT METASTASIS 
Mx - Distant metastasis cannot be assessed 
M0 - No distant metastasis 
M1 - Presence of distant metastasis 
STAGE GROUPING 
Stage  0  Tis  N0  M0 
State  I  T1  N0  M0 
Stage  II  T2  N0  M0 
Stage  III  T3  N0  M0 
    T1  N1  M0 
    T2  N1  M0 
    T3  N1  M0 
Stage   IVA  T4  N0  M0 
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    Any T N1  M0 
    Any T N2  M0 
Stage  IVB  Any T Any N M1 
Stage  IVC  Any T Any N M1 
LIMITATION OF TNM STAGING 
 Important prognostic factor such as fixation of nodes and level of 
nodal status is not included.  False negative physical examination varies 
from 16-60%. 
NODAL STATUS 
 The risk of nodal metastasis from oral cancer is related to several 
factors site of the primary, T stage, depth of invasion, histological grade, 
vascular and perineural invasion. 
 Tumours of tongue have the highest incidence of neck nodes in oral 
cavity cancers.  
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 Tumour thickness > 2cm carry a higher risk of metastasis to regional 
lymphnodes.  
 Endophytic tumours, poor differentiation, increasing T stage and 
neurovascular invasion increase the risk of lymph nodal spread. 
 Positive neck nodes, multiple nodal metastasis carries worse 
prognosis. Extranodal spread is associated with 50% reduction in survival 
when compared with nodes without extranodal spread. Nodes with 
lymphocyte predominant pattern is associated with a good prognosis.  
 There is early nodal involvement in posterior third of tongue lesions 
and incidence of bilateral nodal involvement was more in the same.  
 The level of node in anterior lesion was level II (jugologastric nodes). 
Nodes within level I, III and IV are more frequently involved than many 
other cancers of the head and neck such as oral cavity lesions.  
DISTANT METASTASIS  
 Distant metastasis from primary squamous cell carcinoma of tongue at 
the time of initial diagnosis are exceedingly rare. The presence of advance 
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disease and failure at primary site or neck after treatment are often 
associated with a high risk of distant metastasis.  
 The most common site for distant metastasis are lungs and bones. T4 
lesions and four or more positive nodes are associated with increased 
incidence of metastasis.  
PRINCIPLES OF RADIOTHERAPY  
 Cancer of tongue are of particular interest to radiation oncologists. 
They have an active role in early and advanced disease. The twin advantage 
is easy accessibility and relative tolerance of normal tissue.  
TECHNIQUES 
1. Total dose of definitive radiation therapy is usually 60-65gy to 
primary and neck for clinically evident disease and atleast 60 Gy for 
low-risk cervical disease.  
2. Post operative adjuvant RT – 60 Gy or more to primary and neck.  
3. Brachytherapy – 20-30 Gy to primary along with EBRT.  
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INDICATIONS  
Tumour Control 
 Particularly for small tumour (T1-T2) in both anterior and posterior 
tongue.  
Clinically N0 neck 
 If primary tumour is being treated with definitive RT, then nodes are 
treated electively with external beam radiotherapy.  
Pre-operative 
 For advanced (stage III/IV) or inoperable stage-help in down- staging 
to more operable stage.  
Disadvantages  
- Wound healing delayed due to fibrosis,  
- Assessment of tumour margin will be difficult.  
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Post-operative  
To Primary 
i) In patients with T3/T4 primary. 
ii) Residual microscopic tumour or positive margins.  
To neck  
i) Extracapsular spread.  
ii) Pathologically positive lymph nodes after selective neck 
dissection.  
iii) Multiple positive lymphnodes after radical neck dissection. 
Advantages 
i) Sterilization of residual microscopic cells.  
ii) Better assessment of tumour margin.  
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Disadvantages  
i) Surgical complication may delay the initiation of radiotherapy. 
Palliative  
 When tumour is considered surgically or radio therapeutically 
incurable, a few high dose fraction are given in order to decrease symptoms 
such as pain & bleeding.  
Tumour Recurrence After Surgery  
 EBRT is used for local control. Reexcision surgery can also be 
selected if feasible.  
ADVANTAGES OF RT 
- Centripetal Shrinkage of Tumour. 
- Sterilises lymphatics 
- Facilitates adequate clearance. 
- More useful in ill – defined, posteriorly placed tumour. 
- Functional disability (speech / deglutition) is less.  
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SIDE EFFECTS OF RT  
Acute 
- Mucositis  
- Xerostomia (Dry mouth) 
- Dysguesis (Loss of taste) 
- Dysphagia 
- Erythema  
- Epidermolysis  
Late 
- Soft tissue necrosis 
- Osteroradionecrosis of mandible 
- Hypothyroidism  
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PRINCIPLES OF SURGERY  
 Early stage disease can be managed either by radiotherapy or surgery. 
Both are proved to give equally good results.  
 Advanced lesions need a combination of both radiotherapy and 
surgery. Nodes larger than 3 cms, nodes with capsular infiltration and 
multimodality treatment.  
 When combination of surgery or radiotherapy is used, either could be 
used first depending on the philosophy of treating institution.  
 Resected margins should be free from microscopic involvement of 
cancer. Positive surgical margin carries poor prognosis. Frozen section 
histopathology can be utilized to verify microscopically negative margins.  
 Whenever composite resection is carried out for advanced lesions, the 
resulting excisional defects should be primarily reconstructed. This allows 
prompt healing, early resumption of activities effective rehabilitation and 
shorter hospital stay.  
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ADVANTAGES  
 Many cancers of oral cavity are amenable to surgical excision by oral 
approach. 
 Surgical treatment is required in almost all patients with advanced 
tumours.  
 Requires less time and provides fewer long – term sequelae.  
 Delineation of anatomy will be easier with primary surgery compared 
to surgery after radiotherapy.  
 Histopathological examination of post – operative specimen will be 
accurate after primary surgery.  
DISADVANTAGES 
 Potential risk anaesthesia 
 Post- operative complications 
- Local 
- Respiratory 
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Functional Disabilities 
- Speech 
- Deglutition 
- Cost 
Available Surgical procedures for primary 
- Wide local excision 
- Hemiglossectomy 
- Total glossectomy 
- Total resection of tongue base with total largectomy 
Primarily for T4 posterior lesions. 
 Composite resection – refers to resection of a portion of tongue, floor 
of mouth and segment of mandible. 
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Surgical approaches for tongue resection 
- Transoral 
- Mandibulotomy 
- Pull through procedure 
- Lateral pharyngotomy 
Cervical node metastasis 
 The surgical options available managing neck node are. 
1) Selective neck dissection 
2) Radial neck dissection 
3) Modified radical neck dissection 
Selective neck dissection 
 For T1-T4 lesions and clinically No, neck, provided the neck is not 
previously violated, selected neck dissection is carried out. 
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 The selective neck dissection in case of tongue cancer is 
supraomohyoid neck dissection (SOHND). In SOHND, the nodal levels 
dissected are I-III. The three non-lymphatic structures removed in radical 
neck dissection are preserved in SOHND. There is controversy regarding 
managing N0 neck, whether to observe or to carry out SOHND. 
Arguments for neck surgery 
- High incidence of occult metastatic disease 
- If limited, neck dissection has a low morbidity and mortality. 
- It is impossible to provide the clinical follow-up necessary to detect 
the earliest from N0 to N1. 
- Allowing neck metastasis to develop increases the incidence of distant 
metastasis 
- Cure rate for neck dissection is decreased if gland enlargement occurs 
or multiple nodes appears. 
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Arguments against elective neck surgery 
 Radiation is as effective as neck dissection for non-palpable disease. 
 Results in a number of unnecessary surgical procedures associated 
with inevitable morbidity. 
 Elective neck dissection removes the barrier to the spread of disease 
and may have a detrimental immunological defect. 
 Elective neck dissection gives no guarantee against recurrence of 
tumour in the neck. 
 There is no prospectively controlled trial to support the argument that 
elective neck dissection does improve the prognosis. 
Radical neck dissection 
 The operation removes the lymph-node in the levels I – V and all 
three non- lymphatic structures (spinal accessory nerve, sternomastoid and 
internal jugular vein.) 
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Indicators 
 Significant operable neck disease (N1, N2a, N2b) 
 Some cases of N2c / N3 
 Access prior to pedicled flap reconstruction. 
Contra- indications 
 Untreatable primary tumour 
 Patients unfit for major surgery 
 Distant metastasis  significant bilateral neck disease 
 Inoperable neck disease 
Modified Radical Neck Dissection 
 The operation consists of the removal of lymph node levels I- V with 
preservation of one or more non- lymphatic structures. 
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MRND Type Structures preserved 
I Spinal accessory nerve 
II SAN and IJV 
III SAN, IJV and sternomastoid 
 
RECONSTRUCTION 
 When performing surgical excision of less than one third of the 
tongue, formal reconstruction is not necessary. Indeed the best results are 
obtained by attempting to close the defect or to apply a quilted split- skin 
graft. The base of the residual defect should be fulgrated and then allowed to 
granulate and epitheliase spontaneously. 
 If the volume of the tongue defect does not exceed thirds of the 
original tongue, a radial forearm free flap with microvascular anastomosis 
gives a functional result. 
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 For very large volume defects, for total glossectomy or for deeply 
infiltrating tumours, when the resection extends to the hyoid bone, more 
bulky flaps are required to fill in the deadspace and prevent food pooling. A 
pectoralis major myocutaneous flap is the best method. 
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PRINCIPLES OF CHEMOTHERAPY 
 The role of chemotherapy in tongue cancer is very limited. 
Chemotherapy can not be used as definitive single modality treatment. 
Chemotherapy has been in the palliative, neo-adjuvant, adjuvant settings and 
concurrently with radiation. 
1. Palliative - In recurrent cases after surgery of RT  
   - Very advanced cases. 
2. Previously Untreated cases 
  - Neo adjuvant (On going trials – Result awaited) 
  - Adjuvant 
  - Concurrent with radiation 
Drugs commonly used are 
- Methotrexate 
- 5- fluorouracil 
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- Cisplatin 
- Bleomycin 
- Ifosfamide 
Cis-platin based combination chemotherapy is more effective than 
single-agent chemotherapy. 
 Patients with poor performance status should not be given palliative 
chemotherapy but only symptomatic and supportive treatment. 
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OVERVIEW OF TREATMENT 
ANTERIOR LESIONS 
Stage I and II   - Surgery or Radiotherapy 
      ↓ 
     Equally effective 
Stage III and IV  - Surgery followed by Post-operative  
RT or RT followed by surgery 
Posterior lesion 
 Early stage  - Surgery or Radiotherapy 
 Advanced Stage - Surgery with post-operative RT or  
Chemotherapy and RT, reserving surgery for 
salvage. 
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OBSERVATIONS AND RESULTS 
 A total 63 patients were treated at the Department on Oncology, 
Government Royapettah Hospital, Kilpauk Medical College from September 
2005 to September 2007. 
 The following observations were made.  Among the total 63 cases of 
tongue cancer, the maximum amount of cases occurred in 4th to 6th decades 
of life accounting for 62% of cases.  Of these, males predominate and 
constituted 73% of cases.  The male:female ratio was 3:1. 
Table I 
AGE AND SEX INCIDENCE 
Age Male Female Total 
21-30 - - - 
31-40 6 3 9 
41-50 15 4 19 
51-60 13 2 15 
61-70 18 2 20 
71-80 - - - 
Total 52 11 63 
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 Regarding the site of cancer, among the 63 cases, 42 cases had cancer 
in oral (anterior) tongue and 21 cases were found to have lesion in the 
posterior tongue. 
 77% of cases were T3 and T4 lesions.  64.5% of cases were N1 and 
N2 nodal involvement. 
Table II 
STAGE AT PRESENTATION 
Primary Lesion Node Metastasis 
T1 12 N0 16 M0 63 
T2 16 N1 18 M1 0 
T3 20 N2 24   
T4 13 N3 5   
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Table III 
RISK FACTORS 
Risk No. of Cases 
Smoking and alcohol 40 
Tobacco chewing 6 
Pan masala 5 
No risk factor 12 
 
 Nodal involvement in T1 & T2 lesions were present only in 27.3% of 
cases.  But 83.8% of T3 and T4 lesions presented with palpable neck nodes.  
Nodal involvement was more in posterior tongue lesions (85%) compared to 
oral anterior tongue cancer (60.7%). 
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Table IV 
PATTERN OF CERVICAL METASTASIS 
 Total Cases Palpable nodes No neck 
T1 & T2 28 13 14 
T3 & T4 33 29 3 
Anterior tongue 40 23 16 
Posterior tongue 23 17 2 
 
 External beam radiotherapy played an important role in management 
of tongue cancers.  Thirty cases were taken for primary radiotherapy.  Of 
these five cases defaulted their treatment.  There was residual lesion in 3 
cases.  Among these 3 cases, 2 were taken for surgery like composite 
resection and hemiglossectomy.  Even though surgery was feasible in some 
of these cases, few patients were not willing for post RT surgery. 
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 30 cases were taken for primary radiotherapy.  3 cases had residual 
lesions, thus can be improved if external beam radiotherapy is combined 
with brachytherapy. 
 Total 26 patients were taken up for primary surgery 
(Hemiglossectomy, Hemiglossectomy with neck dissection or composite 
resection). 
Table V 
PRIMARY SURGERY 
Procedure No. of Cases Total 
Wedge excision 4 
Hemiglossectomy 13 
Hemiglossectomy with SOHND 2 
Hemiglossectomy with RND 2 
Composite resection with PMMC flap 3 
Composite resection with MRND  2 
26 
Neck dissection 2  
Observation 5  
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RESULT OF THE STUDY 
Total number of patients 63 
4th and 6th decade 61% 
Male:Female 3:1 
Anterior tongue lesion 42 
Posterior tongue lesion 23 
Stage           T3 and T4 
                    N1 and N2 
80% 
63% 
Smoking and alcoholism in 70% of cases 
Nodal involvement T1 & T2 
                                T3 & T4 
                                Anterior tongue 
                                Posterior tongue 
27.3% 
83.8% 
60.7% 
85% 
Radiotherapy            Palliative 
                                 Primary RT 
                                 No residue 
                                 Residue 
                                 Defaulted 
20 
30 
24 
2 
5 
Primary Surgery 24 
Post – RT Surgery 2 
Chemotherapy 6 
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DISCUSSION 
 In a total of 63 patients tested in present study the maximum age 
incidence was in 4th to 6th decades of life.  Nil cases found in the age group 
of 2nd and 3rd decades, 7th and 8th decades of life. 
Majority of cases were male predominance because of uses of 
smoking, alcoholism, panproducts.  This was in comparison to study by 
MEHROTRA published in Indian Journal Medical Science in which the 
maximum incidence was in age group 51-60 years and male:female ratio 
was 3.27:1. 
COMPARISON STUDY 
AGE AND SEX INCIDENCE  
Contents Present Study Percent 
KMC Study 
Percent 
Literature 
Percent 
Male 73 70 75 
Sex 
Female 27 30 25 
40-50 yrs 30 37 
50-60 yrs 24 23 Age 
60-70 yrs 32 17 
60 
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There is a strong association of cancer tongue with addiction habits 
like smoking, alcoholism, tobacco chewing and use of panproducts.  Among 
the cases, the main risk factor smoking and alcoholism was found in 70% of 
cases.  According to study by BARASCH, the percentage of smokers among 
cases of tongue cancer was 64%. 
RISK FACTORS 
Contents Present Study Percent 
KMC Study 
Percent 
Literature 
Percent 
Smoking 
Alcoholism 
Panproducts 
70 63 64 
 
SITE 
 Anterior site lesions in the tongue are about 70%, Posterior lesions are 
30%.  According to study by MITCHELL anterior lesions are about 72%, 
posterior lesions are 28%. 
 Present Study Percent 
KMC Study 
Percent 
Literature 
Percent 
Anterior 70 71 72 
Posterior 30 29 28 
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Regarding the stage of presentation at the time of diagnosis, most of 
them were advanced lesions.  Public awareness is to be created so that 
patient will present at the department in early stages which would offer a 
better cure. 
STAGE 
 Present Study 
Percent 
KMC Study 
Percent 
Literature 
Percent 
T1-T2 33 35 33 
t3-t4 77 75 72 
 
The neck node involvement was influenced by the T status and 
location of tumour.  According to a study in Trivandrum (world Journal of 
Surgery Oncology) cervical metastasis was present in 35.6% of T1, T2 
lesions and 62.3% of T3, T4 lesions with level II being commonly involved. 
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NODES 
 Present Study 
Percent 
KMC Study 
Percent 
Literature 
Percent 
N0 25 27 24 
N1 28 25 27 
N2 38 37 36 
N3 7 6 8 
 
According to study by LINGC and GRAS JR, Clinically negative 
neck patients in stage I can be observed, but for T2 lesions – SOHND and 
T3, T4 lesions – functional neck dissection should be done.  So prophylactic 
treatment of No neck would be a better option, for better regional control in 
lesions above T2. 
According to study by REGUEIRO, the response rate to EBRT was 
42% which increased to 67% if EBRT was combined with brachytherapy. 
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TREATMENT 
 Present Study 
Percent 
KMC Study 
Percent 
Literature 
Percent 
Surgery 41 20 35 
RT 47 66 52 
CT 4 4 5 
  
 The role of chemotherapy was limited in tongue cancer. 
 Primary RT     - 30 cases 
 Palliative CT    - 3 cases with advanced lesions 
 Post RT chemotherapy for residue - 2 cases 
 Palliative RT    - 20 cases 
 Anterior tongue lesions superceded the posterior lesions. 
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 Most of the cases presented to the department at advanced stage.  So 
measures should be taken to teach the public about early reporting to the 
hospital so that better cure can be obtained. 
 Smoking and alcoholism was present in more than 62% of the cases 
necessitating the need to bring public awareness about ill-effects of tobacco. 
 Nodal involvement was more in T3 and T4 posteriorly placed lesions.  
RT played an important role in the management of carcinoma tongue. 
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CONCLUSION 
¾ Smoking, alcoholism, panproducts are most commonly associated 
risk factors for carcinoma tongue 
¾ Most common in 4th to 6th decade of life Males are more commonly 
affected than females in the ratio of 3:1 
¾ Stage III, IV are common presentation in Carcinoma tongue 
¾ Anterior 2/3rd is the commonest site of involvement 
¾ Nodal involvement was common in T3 and T4 lesions, posteriorly 
placed lesions 
¾ Majority of early lesions (T1 and T2) are best treated surgicaly 
¾ Few cases were down staged by using pre operative radiotherapy and 
chemotherapy followed by surgery. 
¾ Chemotherapy is mainly palliative measure 
¾ The observation and results of the study are in accordance with 
similar study in literature. 
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PROFORMA  
Name   :  
Age    : 
Sex 
Registration No. : 
Date of Admission : 
Date of Discharge : 
Risk factors & Duration  
Symptoms 
- Ulcer  
- Growth 
- Pain, Bleeding 
- Functional Disability 
Examination  
- Site  
- Extension  
- Size  
- Neck Nodes 
 
  
Staging   - TNM 
Investigation  - Biopsy 
- Hemogram  
- CXR 
- CT, MRI 
 
HPE report  
Primary Treatment  
Outcome 
Adjuvant Treatment  
Follow – up 
  
MASTER CHART 
 
S.No. Name Age/Sex IP No. Risk factors Site TNM HPE Primary Treatment Outcome Adjuvant 
RT/CT 
Post RT Surgery 
1 Dhanam 75/f 1511/06 - Postetrior1/3 T3N0M0 adenosquamous Pallattive RT    
2 Nagaraj 60/m 1300/06 S,A Postetrior1/3 T2N 2MO SCC L Hemiglossectomy 
withRND 
 CT RT 
3 Abdul 63/M 141106 C Postetrior1/3 T2N2M0 SCC 
wd 
RT    
4 Swaminathan 43/M 1810/06 S,C Postetrior1/3 T4N2M0 SCC 
PD 
RT POST RT 
resection 
 Totalglossectomy 
Compposite resection 
5 Muthu 72/M 1076/06 S,c Postetrior1/3 T4N1MO SCC 
md 
RT    
6 Mari 54/m 1236/06 S Postetrior1/3 T4N3M0 SCC Palliative RT    
7 Anandha raj 42/m 1526/06 S,A Anterior 
2/3 
T4N 2MO SCC 
wd 
RT    
8 Hussain 65/m 1450/06 S,C Anterior 
2/3 
T2N0M0 adenosquamous Wide excision    
9 Sundaram 40/m 1417/06 s Anterior 
2/3 
T4N 2MO SCC wd RT    
10 Ramani 64/f 1383/06 c Anterior 
2/3 
T4N 0MO SCC 
 
R. Hemiglossectomy 
with  SOHND 
 CT  
11 Nataraj 64/m 710/06 S,C Anterior 
2/3 
T2N 1O SCC Compposite resection with 
PMMCflap 
   
12 lalitha 60/f 1546/06  Anterior 
2/3 
T1N2M0 SCC  R. Hemiglossectomy 
 
   
13 Saravanan 60/M 230/07 SC Posterior1/3 T4N1M0 SCC RT  CT  
14 Danasekar 72/M  1206/06 S,C Anterior 
2/3 CROSSDING 
MIDLINE 
T2N2M0 SCC wd RT   NWS 
15 Lakshmi 46/f 1129/06 C Anterior 
2/3 
T4N2M0 SCC 
PD 
RT    
16 Jeyaraman 32/M 1338/06 S,C,P Anterior 
2/3 
T4n2m0 SCC 
 
RT    
17 selva 50/m 1631/06 S/C Anterior 
2/3 
T1N0M0 SCC Wd R 
Hemiglossectomy 
withSOHND 
   
18 babu 39/m 11631/06 S,P Anterior 
2/3 
T1N0M0 SCC Wd R 
Hemiglossectomy 
Nodes after 
8 mnths 
 RND 
19 Dhayalan 50/M 864/06 S,C Anterior 
2/3 
T4N1M0 SCC PD RT    
20 Syed 42/m 488/06 S,C,P Anterior 
2/3 
T2N1M0 SCC Lt Hemiglossectomy with 
PMMCflap 
  RT 
21 Mohan 60/m 981/06  Anterior 
2/3 
T3N0M0 SCC RT    
22 Palani 63/m 1031/06 S,C Anterior 
2/3 
T3N1M0 SCC RT    
23 RANI 45/F 1061/06 C Anterior 
2/3 
T2N2M0 SCC RT   NWD 
24 Perumal 63/m 235/06 S,C Posterior1/3 T4N1MO scc RT  CT  
25 Selvam 32/M 1295/06 S,A,P Anterior 2/3 T2N1M0 SCC Lt Hemiglossectomy with 
Type 1 MRND 
   
26 Prem 56/m 571/07 S,A Posterior1/3 T34N2M0 SCC RT    
27 Palani 67/m 537/07 S,A Posterior1/3 T34N2M0 SCC RT    
28 Balu 48/m 5148/07 S Anterior 2/3 T1N0M0 SCC Partialglossectomy    
29 Pondy 68/m 430/07 S,C Anterior 2/3 T1N0M0 SCC Wide Excision    
30 Rani 43/f 488/07 C Anterior 2/3 T3N1M0 SCC   Pallative 
RT ,CT 
 
31 Anbu 50/m 492/07 S,A Posterior1/3 T3N2M0 SCC RT    
  
32 Muthu 43/m 403/07 S Central T2N2M0 SCC   RT,CT  
33 Basha 65/m 380/07 S,C Anterior 
2/3 
T2N0M0 SCC Compposite resection with 
Type 1 MRND 
   
34 Kumar 60/m 1081/07 S,C Hemiglossectomy T34N3M0 SCC RT  CT  
35 Raja 34/m 1308/07 S,P Anterior 
2/3 
T4N2M0 SCC RT,CT  CT  
36 Sakunthala 35/f 434/07  Anterior 
2/3 
T1N0M0 SCC Wide Excision    
37 Mallika 53/f 238/07 C Anterior 
2/3 
T2N0M0 SCC RT    
38 Annamalai 45/f 217/0-7 C Anterior 
2/3 
T1N0M0 SCC Hemiglossectomy    
39 Sandhanam 30/m 155/07 S,P Posterior1/3 T3N3M0 SCC RT    
40 Lalitha 60/f 153/07 C Anterior 
2/3 
T1N1M0 SCC Hemiglossectomy with RND    
41 Madhavan 40/m 541/07 S,C Posterior1/3 T4N3M0 SCC RT  CT  
42 Kumari 65/f 66/07  Anterior 
2/3 
T1N0M0 SCC Hemiglossectomy    
43 Shanmugam 45/m 25/07 S,C Anterior 
2/3 
T4N2M0 SCC RT    
44 Prama 64/m 24/07 S,C Posterior1/3 T4N3M0 SCC RT,CT    
45 Kasim 53/m 93/07 S,C Posterior1/3 T3N0M0 SCC RT    
46 Veeran 45/m 44/07 S Posterior1/3 T4N1M0 SCC RT    
47 Rethinam 53/m 400/07 C Posterior1/3 T4N1M0 SCC RT    
48 Selvi 64/f 1383/07  Anterior 
2/3 
T1N2M0 SCC Hemiglossectomy with 
SOHND 
   
49 Sundar 44/m 1250/07 S Anterior 2/3 T2N1M0 SCC Compposite resection    
50 Mani 65/m 1349/07 S,C Anterior 2/3 T3N1M0 SCC Hemiglossectomy with RND   CT,RT 
 Hussian 44/m 1450/07 S Anterior 2/3 T2N0M0 SCC Wide Excision    
51 Murugan 54/m  1542/07 S,C Anterior 2/3 T2N0M0 SCC Compposite resection with 
PMMCflap 
   
52 Thangam 56/f 1546/07  Posterior1/3 T4N2M0 SCC RT 
With Hemiglossectomy with 
RND 
   
53 Sethu 60/m 1310/07 S,C Posterior1/3 T4N1M0 SCC RT    
54 Syed 40/m 485/07 S,C Anterior 2/3 T2N1M0 SCC Hemiglossectomy with 
PMMC flap 
   
55 Raman 50/m 864/078 S,C Anterior 2/3 T4N1M0 SCC RT    
56 Raja 48/m 865/07 S Anterior 2/3 T4N2M0 SCC RT    
57 Ramaraj 37/m 1089/06 P Anterior 2/3 T3N1M0 SCC RT Residue   Compposite resection 
58 Arun 32/m 1295/07 P,S Anterior 2/3 T2N1M0 SCC Hemiglossectomy with 
MRND 
   
59 Manoj  39/m 1107/07 S,A Anterior 2/3 T1N0M0 SCC Hemiglossectomy Nodes after 
7 mnths 
 MRND done 
60 Manju 46/f 1267/07 C Anterior 2/3 with 
posterior extension 
T4N2M0 SCC RT, CT  CT  
61 Jeyaraman 45/m 138/07 S,C Posterior1/3 T4N2M0 SCC RT  CT  
62 Palayam 50/m 1031/07 S,C Anterior  2/3  T3N3M0 SCC RT    
63 Seetharaqman 65/m 381/07 S,C Anterior  2/3 T2N1M0 SCC Compposite resection with 
PMMC flap 
   
 
S - Smoking  SOHND - Supra omohyoid node dissection 
A - Alcoholism  RND  - Radical neck dissection 
P - Panproducts  MRND  - Modified radical neck dissection 
C - Tobacco chewing  NWS  - Not willing for sugery 
RT - Radiotherapy  SCC  - Squamous cell carcinoma 
CT - Chemotherapy  WD  - Well differentiated 
